Prices for lab monkeys in China are set to climb to their highest level since the pandemic, driven by surging demand from the country’s fast-growing biotech sector.
The cost of the monkeys — a proxy for the volume of clinical trials — is projected to reach Rmb150,000 ($21,000) at the start of 2026, up from an average of Rmb103,000 in 2025. Prices have risen in recent months as Chinese biotech companies accelerate research and development following a record wave of investment.
“Many more projects have been initiated in 2025 following strong investment . . . At the same time, monkey supplies are limited, which has pushed up prices,” said UBS pharma analyst Chen Chen, who compiled the data.
您已阅读26%（696字），剩余74%（1995字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。